 |
|
|
|
|
OUR TEAM
Mr. Mikael Ørum | Founder & Partner
Mikael Oerum is co-founder and Partner of Ventac Partners since 2002. He holds more than 30 years of executive experience in the biotechnology and finance sectors. He has a proven track record in identifying business opportunities, developing and executing strategic business plans, fund raising, and international deal making. Since 2005, Mikael Oerum serves as CEO and Chairman (and co-founder) of Avexxin.
Mikael Oerum is serving as Board Member and Chairman of several biotech companies. These include Neuroscience Technologies S.L.P. (Spain), and Neuroscience Technologies Limited (UK), and HUNT Biosciences AS (Norway) and Idogen AB (Sweden). Furthermore, he serves on the Scientific Advisory Board of Virginia Tech Bioinformatics Institute (USA) and as Vice Chairman of Medicon Valley Alliance (Denmark/Sweden), and Nansen Neuroscience Network (Norway).
In 1995, he co-founded Exiqon A/S (Denmark), and served as CEO of the company until 2002. The company is listed on the Nasdaq OMX Stock Exchange. He is also co-founder of Cureon A/S, now Santaris Pharma A/S (Denmark).
Within the life science sector Mikael Oerum has over time served on several government committees, and has participated in international projects focusing on healthcare, industrial growth and biotech initiatives. Among these he has headed two major projects in 2003-04 and 2008-09 covering Hong Kong and mainland China for HKSAR/HKSTP. Mikael Oerum serves as advisor to several universities on matters of commercialization of life science research as well as to several other life sciences companies. Mikael Oerum is a frequent speaker and moderator at conferences and at university staged entrepreneurial courses within biotech and medtech.
Mikael Oerum has an education in banking, finance and law from Copenhagen Business School, Danish Bankers Academy, Copenhagen Business College and Copenhagen University.
Return to Our Team page
